Clinical trials are slow and costly, built around the research centers that study local participants. Building clinical trials around patients in their homes and community through remote visits and monitoring could enhance recruitment and increase convenience for participants. This study evaluated different trial settings, a decentralized arm via telemedicine center (virtual study conduct), a conventional arm via health clinic (onsite study conduct) and a mixed model arm. Acute low-back pain patients (20-65 years) were recruited to this non-interventional trial in Switzerland. The study consisted of a screening period and a 2-week data collection period using direct data capture (eSource), electronic informed consent form (eICF), electronic diary (eDiary) and wearable actigraphy sensor. A higher number of patients were enrolled in the decentralized arm (N = 18) compared to the conventional arm (N = 5) and none in the mixed model arm. The decentralized arm consisted of a diverse population with increased participation from rural areas. In the decentralized arm 89% of enrolled patients completed the study compared to 60% in the conventional arm. All the patients reported satisfaction with the use of eICF, eDiary and remote visits; whereas patients reported a lower level of satisfaction with the wearable sensor. The decentralized setting was operationally feasible and well accepted by patients. Faster recruitment and improved access to patients was observed in the decentralized arm. This study supports broader adoption of the decentralized model in clinical trials, though further investigations in larger interventional trials are needed to confirm the benefits from this patient-centric approach.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072894 | PMC |
http://dx.doi.org/10.1016/j.conctc.2018.06.008 | DOI Listing |
Clin Chim Acta
December 2024
Unilabs Group, Geneva, Switzerland. Electronic address:
Background: Alternative means of blood sampling continue to grow due to the scarcity of phlebotomists and the need for person-centered care. It is crucial to consistently support these alternative blood sampling innovations with scientific evidence to guarantee the quality of care, especially when implementing for instance Lateral Upper-arm Blood Collection (LUBC) for non-trained professionals at home. Knowledge gaps remain in how to quantify imprecision introduced by the collection method and its impact on clinical use.
View Article and Find Full Text PDFEClinicalMedicine
December 2024
Center for Tuberculosis, University of California San Francisco, San Francisco, USA.
Background: Rapid diagnosis of tuberculosis (TB) is important for improving outcomes and reducing transmission. Previous studies assessing the impact of Xpert MTB/RIF (Xpert), a molecular assay that provides results within 2 h, on mortality have been inconclusive. In this planned analysis of a pragmatic cluster-randomized trial in Uganda, we assessed whether a multicomponent strategy, including decentralized Xpert testing, decreased mortality among adults evaluated for TB.
View Article and Find Full Text PDFRespirology
December 2024
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Background And Objective: Pulmonary fibrosis, a manifestation of interstitial lung disease, is frequently associated with anxiety. The objective of this study, COMPANION, was to assess the anxiolytic efficacy of Almee, a digital cognitive behavioural therapy for patients with pulmonary fibrosis, compared to treatment as usual.
Methods: COMPANION was a randomized, controlled, open-label and partly reader-blinded, decentralized, clinical trial conducted in the United States.
J Acquir Immune Defic Syndr
December 2024
Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
bioRxiv
October 2024
University of Glasgow, Glasgow, United Kingdom.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!